The role of quality control in a skin bank: Tissue viability determination

Cell and Tissue Banking

Volumn 3, Issue 1, 2002, Pages 3-10

  Alotto, D ^a   Ariotti, S ^a   Graziano, S ^b   Verrua, R ^b   Stella, M ^a   Magliacani, G ^a   Castagnoli, C ^a  

^a CTO HOSPITAL   (Italy)

^b Piedmont Found Studs Res on Burns   (Italy)

Author keywords

Allografts; Cryopreserved skin; Quality control; Skin Storage; Tissue viability

Indexed keywords

CELL ENZYME; FORMAZAN; PRESERVATIVE; TETRAZOLIUM; TETRAZOLIUM DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; BURN; CELL CULTURE; CELL METABOLISM; CELL SUSPENSION; COHORT ANALYSIS; COLORIMETRY; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CRYOPRESERVATION; FIBROBLAST; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY CONTROL; QUANTITATIVE ASSAY; RELIABILITY; SENSITIVITY ANALYSIS; SKIN ALLOGRAFT; SKIN CULTURE; SPECTROSCOPY; SURGICAL TECHNIQUE; THAWING; TISSUE ENGINEERING; VALIDATION PROCESS;

EID: 0242448195     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021846703301     Document Type: Article

References (18)

1. Alexander J.W., MacMillan B.G., Law E. and Kittur D.S. 1981. Treatment of severe burns with widely meshed skin autografts and meshed allografts overlay. J. Trauma. 21: 433-438.
2. Bank H.H. and Schmehl M.K. 1989. Parameter of evaluation of viability assays: accuracy, precision, specificity, sensitivity, and standardization. Cryobiology 26: 203-211.
3. Bravo D., Rigley T.H., Gibran N., Strong D.M. and Newman-Gage H. 2000. Effect of storage and preservation methods on viability in transplantable human skin allografts. Burns 26: 367-378.
4. Chang P., Rosenquist M.D. II, Lewis R.W. and Kealey G.P. 1998. A study of functional viability and metabolic degeneration of human skin stored at 4 °C. J. Burn. Care. Rehabil. 19: 25-28.
5. Cuono C.B., Langdon R., Birchall N., Barttelbort S. and McGuire J. 1987. Composite autologous-allogeneic skin replacement. Development and chemical application. Plast. Reconstr. Surg. 80: 626-637.
6. Fahmy F.S., Navsaria H.A., Frame J.D., Jones C.R. and Leigh I.M. 1993. Skin graft storage and keratinocyte viability. Br. J. Plast. Surg. 46: 292-295.
7. Hira M., Taijma S. and Yamamoto Y. 1992. The metabolism of skin grafts stored with excess carbon dioxide. Plast. Reconstr. Surg. 89: 1122-1128.
8. Ingham E., Matthews B., Kearney J.N. and Gowland G. 1993. The effects of variation of cryopreservation protocols on the immunogenicity of allogeneic skin grafts. Cryobiology 30: 443-458.
9. Kearney J.N., Wheldon N.A. and Gowland G. 1990. Cryopreservation of skin using a murine model: validation of a prognostic viability assay. Cryobiology 27: 24-30.
10. Klein M.B., Shaw D., Barese S., Chapo A. and Cuono C.B. 1996. A reliable and cost-effective in vitro assay of skin viability for skin bank and burn centers. J. Burn. Care. Rehabil. 17, n.6: 565-570.
11. May S.R. and DeClement F.A. 1981. Skin banking III. Cadaveric allograft skin viability. J. Burn. Care. Rebabil. 2: 128-140.
12. May S.R. and Roberts D.P. 1988. Development of a passive device for freezing large amounts of transplantable skin at one time in a -70 °Cmechanical refrigerator. Cryobiology 25: 186-196.
13. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63.
14. Pegg D.E. 1989. Viability assays for preserved cells, tissues, and organs. Cryobiology 26: 212-231.
15. Scudiero D.A., Shoemaker R.H., Paull K.D., Monks A., Tierney S., Nofziger T.H. et al. 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 48: 4827-4833.
16. Vistica D.T., Skehan P., Scudiero D., Monks A., Pittman A. and Boyd M.R. 1991. Tetrazolium-based assays for cellular viability: a critical examination of selected parameters affecting formazan production. Cancer Res. 51: 2515-2520.
17. Yang H., Jia X.M., Acker J.P., Lung G. and McGann L.E. 2000. Routine assessment of viability in split-thickness skin. J. Burn. Care. Rahabil. 21: 99-104.
18. Zieger M.A.J., Tredget E.E. and McGann L.E. 1993. A simple, effective system for assessing viability in split-thickness skin with the use of oxygen consumption. J. Burn. Care. Rehabil. 14: 310-318.